This topic contains a solution. Click here to go to the answer

Author Question: Cough and cold medications that contain a sympathomimetic decongestant such as phenylephrine should ... (Read 22 times)

sam.t96

  • Hero Member
  • *****
  • Posts: 570
Cough and cold medications that contain a sympathomimetic decongestant such as phenylephrine should be used cautiously in what population:
 
  1. Older adults
  2. Hypertensive patients
  3. Infants
  4. All of the above

Question 2

Howard is a 72-year-old male who occasionally takes diphenhydramine for his seasonal allergies. Monitoring for this patient taking diphenhydramine would include assessing for:
 
  1. Urinary retention
  2. Cardiac output
  3. Peripheral edema
  4. Skin rash



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jessofishing

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

4

Answer to Question 2

1




sam.t96

  • Member
  • Posts: 570
Reply 2 on: Jul 24, 2018
YES! Correct, THANKS for helping me on my review


billybob123

  • Member
  • Posts: 336
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

In 1864, the first barbiturate (barbituric acid) was synthesized.

Did you know?

After 5 years of being diagnosed with rheumatoid arthritis, one every three patients will no longer be able to work.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library